Active substance
Results for the substance regorafenib
1 result
About this active substance
Regorafenib is a medication used to treat certain types of cancer, including metastatic colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma. It is a multikinase inhibitor that works by blocking several enzymes involved in the growth and spread of cancer cells.
The medication is taken orally, usually in tablet form, and should be used as directed by your doctor. It is important to follow the prescribed dosage and undergo regular check-ups to monitor the effects of the treatment.
Side effects may include fatigue, nausea, diarrhea, high blood pressure, or skin rashes. In rare cases, severe adverse effects such as liver damage or bleeding may occur, requiring immediate medical attention.
Patients should inform their doctor about any other medications being used or pre-existing conditions, such as liver disease or hypertension, to ensure the safe use of regorafenib.
The medication is taken orally, usually in tablet form, and should be used as directed by your doctor. It is important to follow the prescribed dosage and undergo regular check-ups to monitor the effects of the treatment.
Side effects may include fatigue, nausea, diarrhea, high blood pressure, or skin rashes. In rare cases, severe adverse effects such as liver damage or bleeding may occur, requiring immediate medical attention.
Patients should inform their doctor about any other medications being used or pre-existing conditions, such as liver disease or hypertension, to ensure the safe use of regorafenib.